Navigation Links
New lung cancer research presented at CHEST 2008
Date:10/27/2008

#7725
YOUNGER PATIENTS WITH LUNG CANCER HAVE BETTER SURVIVAL

(Tuesday, October 28, 1:00 PM EST)

Lung cancer in younger patients may exhibit distinct clinical features than lung cancer in older patients, including better survival rates at each disease stage. Researchers from Stanford Cancer Center in California compared disease characteristics and survival of lung cancer patients aged 15 to 39 years at diagnosis with patients aged ≥40 years at diagnosis. The age-adjusted incidence rate of lung cancer in patients aged 15 to 39 years was 1.2 per 100,000, whereas the rate in patients aged ≥40 years was 141 per 100,000. A higher proportion of younger patients (57 percent) had distant disease at diagnosis compared with older patients (51 percent). Mean 5-year cause-specific survival was 34 percent in the group of patients aged 15 to 39 years and 16 percent in the group aged ≥40 years. In addition, at each disease stage, mean 1- and 5-year cause-specific survival rates were better in the younger group.

#7701
HERBAL REMEDIES MAY HELP PATIENTS WITH ADVANCED LUNG CANCER

(Wednesday, October 29, 1:00 PM EST)

The use of herbal remedies may be an effective supportive therapy to control symptoms and improve quality of life in patients with advanced stage lung cancer. Researchers from Jafary Medical Clinics in West Virginia followed 15 patients with end-stage primary lung cancer who failed to improve with a conventional treatment of chemotherapy and radiation therapy. Patients were treated with American ginseng for fatigue, morphine sulfate for control of severe dyspnea and pain, licorice root powder for control of severe coughing spells, and bilevel pressure ventilation for respiratory depression related to IV morphine. Two patients also were taking oldenlandia, a Chinese herb for lung cancer. Results showed that licorice and ginseng were effective therapies for the majority of patients, and morphine, used as nebulizer in two patients, was effective in the control of marked dyspnea and pain. One patient lived 4 months using the supportive therapy, while the remaining patients lived 6 to 12 weeks.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related medicine news :

1. Doctors Test Advanced Tool for Treating Prostate Cancer
2. Hooters to Hooters 80 Mile Bicycle Ride Supporting Local American Cancer Society Unit
3. Statins Lower Risk of Clots in Cancer Patients
4. Most Off-Label Cancer Drug Use for Palliative Care
5. Get Screened Video Contest Throws a Spotlight on the Importance of Colorectal-Cancer Screening
6. MicroRNAs make for safer cancer treatments
7. Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan
8. Aflac Cancer Center and Blood Disorders Service Unveils New Carl Edwards Triage Room
9. USC Cancer Center Announces Contribution By Larry and Judy Freeman
10. Study finds that practice makes perfect in lung cancer surgery
11. Researchers Find More Genes Linked to Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... 2016 , ... WestHarbor Growth Partners, a growth, expansion and ... Grow Healthy Vending’s newly revamped brand campaign. Grow Healthy Vending is headquartered ... in North America with locations across the United States as well as internationally. ...
(Date:5/2/2016)... New York, NY (PRWEB) , ... May 02, 2016 , ... ... Highlighting the year’s best in pet gear and toys, leading product review site ... TTPM Pets Paw of Excellence Awards at their Spring Showcase at the Metropolitan ...
(Date:5/2/2016)... Illinois (PRWEB) , ... May 02, 2016 , ... MedPro ... modernized mail back service. MedPro now offers its mail back service for an ... offer; we are now able to provide service to all of the clients in ...
(Date:5/2/2016)... ... May 02, 2016 , ... Further establishing itself as a leader ... new WHIMZEES Variety Value Boxes were selected from over 1,000 entrants as a winner ... , WHIMZEES natural dental chews for dogs are a favorite product among pet-parents worldwide, ...
(Date:5/2/2016)... , ... May 02, 2016 , ... Dr. Rassouli, ... health and cognitive decline. According to the research, which was published in the “Journal ... of cognitive decline, and about 5.4 million Americans have Alzheimer’s disease. The study found ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
(Date:4/27/2016)... , April 27, 2016 ... titled, "Skincare Devices Market - Global Industry Analysis, Size, ... to the report, the global skincare devices market was ... anticipated to expand at a CAGR of 10.1% from ... 2023. Browse the full Skincare Devices Market (Treatment ...
Breaking Medicine Technology: